Editorial
doi: 10.4081/reumatismo.2011.125.
[Biotechnological innovation to the benefit of the rheumatic patient]
[Article in
Italian]
- PMID: 22257913
- DOI: 10.4081/reumatismo.2011.125
Item in Clipboard
Editorial
[Biotechnological innovation to the benefit of the rheumatic patient]
[Article in
Italian]
Reumatismo.
.
No abstract available
Similar articles
-
Costs of pain in rheumatology.Reumatismo. 2014 Jun 6;66(1):103-7. doi: 10.4081/reumatismo.2014.771. Reumatismo. 2014. PMID: 24938203 Review.
-
The Corrona US registry of rheumatic and autoimmune diseases.Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S96-S99. Epub 2016 Oct 19. Clin Exp Rheumatol. 2016. PMID: 27762197 Review.
-
[Can we treat with modern antirheumatics? Costs of NSAID treatment].Pharm Unserer Zeit. 2002;31(2):206-15. doi: 10.1002/1615-1003(200203)31:2<206::AID-PAUZ206>3.0.CO;2-#. Pharm Unserer Zeit. 2002. PMID: 11977457 Review. German. No abstract available.
-
Do rheumatology cost-effectiveness analyses make sense?Rheumatology (Oxford). 2004 Jan;43(1):4-6. doi: 10.1093/rheumatology/keh034. Epub 2003 Oct 1. Rheumatology (Oxford). 2004. PMID: 14523227 No abstract available.
-
Rheumatologic rehabilitation: the great expectation for rheumatic patients.Reumatismo. 2012 Mar 16;64(1):1-6. doi: 10.4081/reumatismo.2012.1. Reumatismo. 2012. PMID: 22472777 No abstract available.